Bank Of America Corp Standard Biotools Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Standard Biotools Inc. stock. As of the latest transaction made, Bank Of America Corp holds 185,246 shares of LAB stock, worth $339,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

185,246

Previous 257,680 28.11%

Holding current value

$339,000

Previous $456,000 21.71%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.42 - $2.35 $102,856 - $170,219	-72,434 Reduced 28.11%	185,246 $357,000
Q2 2024 Aug 14, 2024	SELL	$1.65 - $2.92 $624,787 - $1.11 Million	-378,659 Reduced 59.51%	257,680 $456,000
Q1 2024 May 15, 2024	BUY	$1.87 - $2.78 $1.04 Million - $1.54 Million	554,781 Added 680.23%	636,339 $1.72 Million
Q4 2023 Feb 14, 2024	BUY	$1.59 - $2.73 $128,836 - $221,209	81,029 Added 15317.39%	81,558 $180,000
Q2 2023 Aug 14, 2023	SELL	$1.47 - $2.56 $1,486 - $2,588	-1,011 Reduced 65.65%	529 $1,000
Q1 2023 May 12, 2023	BUY	$1.3 - $2.24 $1,437 - $2,477	1,106 Added 254.84%	1,540 $3,000
Q4 2022 Feb 10, 2023	BUY	$0.93 - $1.52 $390 - $638	420 Added 3000.0%	434 $0
Q3 2022 Nov 14, 2022	SELL	$1.1 - $2.06 $862 - $1,615	-784 Reduced 98.25%	14 $0
Q2 2022 Aug 12, 2022	SELL	$1.6 - $3.99 $49,771 - $124,116	-31,107 Reduced 97.5%	798 $1,000
Q1 2022 May 16, 2022	BUY	$2.8 - $3.96 $7,585 - $10,727	2,709 Added 9.28%	31,905 $115,000
Q4 2021 Feb 08, 2022	SELL	$3.63 - $6.13 $21,881 - $36,951	-6,028 Reduced 17.11%	29,196 $115,000
Q3 2021 Nov 15, 2021	SELL	$5.5 - $7.41 $16,247 - $21,889	-2,954 Reduced 7.74%	35,224 $232,000
Q2 2021 Sep 13, 2021	BUY	$4.35 - $6.35 $166,074 - $242,430	38,178 New	38,178 $236,000

Others Institutions Holding LAB

# of Institutions

142

Shares Held

279M

Call Options Held

27.2K

Put Options Held

34.1K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $144M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Standard Biotools Inc. Transaction History